Goldman Sachs (NYSE:GS) is recognizing Adaptive Biotechnologies’ Chad Robins, President, Chief Executive Officer and Co-Founder, and Harlan Robins, Chief Scientific Officer and Co-Founder, as part of the 100 Most Intriguing Entrepreneurs of 2015 at its Builders + Innovators Summit in Santa Barbara, California.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151014006626/en/
Adaptive Biotechnologies Co-Founders, Chad and Harlan Robins (Photo: Business Wire)
Goldman Sachs selected Chad and Harlan Robins as part of 100 entrepreneurs from multiple industries to be honored at the two-day event. Brothers, Chad and Harlan Robins, built Adaptive Biotechnologies based on a ground-breaking technology platform that profiles the adaptive immune system and revolutionizes the way we discover, diagnose and treat diseases. It takes years of dedication and commitment to get a biotech company off the ground and finding success is often a futile effort. But not for an adventuresome entrepreneur with a keen business acumen and an innovative theoretical physicist with a passion for healthcare — together, with their ever-growing team, they have built the awareness of a novel tool while demonstrating its many applications in research, clinical and therapeutic contexts. Watch the Builders + Innovators video on Adaptive Biotechnologies: http://www.goldmansachs.com/our-thinking/technology-driving-innovation/builders-and-innovators-2015/index.html?videoId=109321
"It’s a privilege to be recognized among such innovative thinkers who have made such exciting advances in highly competitive industries." said Chad Robins. “It’s a massive team effort to get any company off the ground and to keep it growing at an ever-accelerating pace. The integrity, passion and dedication of those at Adaptive have been pivotal to our success as a company to date, and I am more convinced than ever of the transformative impact that Adaptive will have as we continue on our path to change the course of medicine.”
"We are honored to recognize Chad and Harlan Robins as part of the most intriguing entrepreneurs of 2015," said David Solomon, co-head of investment banking at Goldman Sachs. "This is an exciting time for entrepreneurs. This is the fourth year that we’ve hosted the Builders + Innovators Summit and continue to be amazed by what happens when a diverse group of seasoned and emerging business leaders -- the builders and innovators – come together to discuss how to drive innovation, create jobs, and build enduring organizations."
For more than 145 years, Goldman Sachs has been advising and financing entrepreneurs as they launch and grow their businesses. In addition to honoring 100 entrepreneurs, the summit consists of general sessions and clinics led by Goldman Sachs experts, seasoned entrepreneurs, academics and business leaders as well as resident scholars.
About Adaptive Biotechnologies®
Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Adaptive is bringing the accuracy and sensitivity of its immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. Adaptive also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151014006626/en/
Contacts:
April Falcone, 206-939-3835
media@adaptivebiotech.com
